相关实验视频
Updated: Jul 23, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.9K
远程连接:为接受胰岛素治疗的1型糖尿病患者实施远程数据共享
Monica Grimaldi1, Lisania Cardenas1, Aleida Maria Saenz1
1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL.
概括
这项研究详细介绍了远程收集胰岛素数据的改进,以改善糖尿病护理. 它强调了改善糖尿病相关疾病管理质量的最佳实践.
科学领域:
- 内分泌学 在内分泌学.
- 糖尿病管理 糖尿病管理
- 医疗信息学 医疗信息学
背景情况:
- 质量改善举措对于改善糖尿病管理中的患者护理至关重要.
- 有效的数据收集对于监测和改善糖尿病患者治疗结果至关重要.
- 远程数据收集为患者的方便和临床效率提供了潜在的好处.
研究的目的:
- 描述一项旨在改善远程收集胰岛素数据的倡议.
- 分享最佳实践和策略,以提高糖尿病护理机构的质量.
主要方法:
- 实施新的系统或协议,用于远程检索胰岛素数据.
- 专注于佛罗里达州南部的一个学术医疗中心.
主要成果:
- 该计划成功增强了远程收集胰岛素数据的功能.
- 确定了改善糖尿病护理数据管理的关键策略和最佳实践.
结论:
- 改进的远程数据收集可以积极影响使用胰岛素的患者的护理质量.
- 分享这些质量改善工作可以指导其他机构优化糖尿病管理.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
213
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
213
Insulin Formulations: Types and Delivery
232
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
232
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Diabetes: Management and Pharmacotherapy
319
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K

